WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 28, 2006--Interleukin Genetics, Inc. (AMEX:ILI) reported today that it has signed two new Purchase Agreements for genetic tests with Access Business Group International LLC, a subsidiary of Alticor Inc. Interleukin also reported that it has amended its Note Purchase and Stock Purchase Agreements with Pyxis Innovations, Inc., another affiliate of Alticor, to provide Interleukin with access to up to an additional $3.5 million of borrowing for general working capital purposes.
